fluoxetine and propranolol

fluoxetine has been researched along with propranolol in 74 studies

Research

Studies (74)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (8.11)	18.7374
1990's	11 (14.86)	18.2507
2000's	16 (21.62)	29.6817
2010's	39 (52.70)	24.3611
2020's	2 (2.70)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Caron, G; Ermondi, G	1
Abraham, MH; Acree, WE; Ibrahim, A	1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H	1
Ahman, M; Holmén, AG; Wan, H	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F	1
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ	1
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ	1
Buckley, DB; Funk, RS; Hensley, T; Kazmi, F; Loewen, GJ; Parkinson, A; Pope, C	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Bryce, GF; Jacoby, JH	1
Locke, CA; Rothschild, AJ	1
Fleischhacker, WW	1
Boura, AL; Jansakul, C; King, RG	1
Andrews, P; Harder, A; Thomas, H	1
Snoddy, AM; Tessel, RE	1
Marsden, CA; Stolz, JF	1
Delashaw, JB; Dement, WC; Foutz, AS; Guilleminault, C	1
Mogilnicka, E	1
Klemfuss, H; Kripke, DF	1
Drake, WM; Gordon, GD	1
Kropp, BP; Springer, JP; Thor, KB	1
Callaway, CW; Geyer, MA; Rempel, NL	1
Alhaider, AA; Mustafa, AA	1
Kleven, MS; Koek, W	1
Daws, LC; Frazer, A; Lopez, R	1
Chariot, J; Nagain-Domaine, C; Presset, O; Rozé, C	1
Hodgson, WC; Ramasamy, S; Ventura, S	1
Chapman, KE; Kelly, PA; Lai, M; McCormick, JA; Seckl, JR; Yau, JL	1
Amelin, AV; Ignatov, IuD; Skoromets, AA	1
Swant, J; Thompson, AM; Wagner, JJ	1
Balsara, JJ; Gaikwad, RV; Gaonkar, RK; Jadhav, JH; Jadhav, SA; Thorat, VM	1
Aggelopoulou, N; Flevari, P; Karabela, G; Kremastinos, DT; Leftheriotis, D; Livanis, EG; Theodorakis, GN	1
Juvonen, R; Korhonen, LE; Pelkonen, O; Raunio, H; Tolonen, A; Turpeinen, M; Uusitalo, J	1
Hallifax, D; Houston, JB	1
Platt, DM; Rowlett, JK; Spealman, RD	1
Ducharme, J; Gauvin, C; Morin, PE; Panetta, R; Walles, M	1
Bhide, N; Gudelsky, GA; Pachmerhiwala, R; Straiko, M	1
Cui, CC; Feng, J; Xu, HL; Yi, LT; Zhan, X; Zhou, LP	1
Escher, BI; Neuwoehner, J	1
Arrhenius, A; Backhaus, T; Blanck, H; Brosche, S; Johansson, P; Porsbring, T	1
Furutani, K; Inanobe, A; Kurachi, Y; Ohno, Y; Yamakawa, Y	1
Aydın, B; Aykaç, A; Cabadak, H; Gören, MZ	1
Barceló, D; Kasprzyk-Hordern, B; López-Serna, R; Petrović, M	1
Fabbri, E; Franzellitti, S	2
Buratti, S; Fabbri, E; Franzellitti, S; Valbonesi, P	1
Margiotta-Casaluci, L; Sumpter, JP	1
Fitzgerald, PJ; Maren, S; Seemann, JR	1
Brooks, BW; Buratti, S; Chambliss, CK; Du, B; Fabbri, E; Franzellitti, S; Haddad, SP	1
Barata, C; Campos, B; Rivetti, C	1
Batley, GE; Hutchinson, TH; Kumar, A; Nidumolu, B	1
Ding, J; Li, Y; Lu, G	1
Colecraft, HM; Ducy, P; Guo, XE; Huang, YY; Mann, JJ; Ortuño, MJ; Paone, R; Robinson, ST; Subramanyam, P	1
Fabbri, E; Pasteris, A; Varano, V	1
Nielsen, ME; Roslev, P	1
Bradaschia-Correa, V; Buchalter, DB; Ihejirika, R; Josephson, AM; Leclerc, K; Lee, S; Leucht, P; Litwa, HP; Markus, D; Remark, LH; Tejwani, R; Wong, MZ; Yim, NL	1
Barbosa, J; Cabral, HN; Duarte, IA; Fonseca, VF; Freitas, A; Lemos, MFL; Novais, SC; Pouca, ASV; Rato, LD; Reis-Santos, P	1

Reviews

3 review(s) available for fluoxetine and propranolol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Current views on migraine and anti-migraine preparations]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 2003, Issue:10 Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics; Analgesics, Non-Narcotic; Antidepressive Agents; Aza Compounds; Brain; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Clonidine; Fluoxetine; Humans; Imidazoles; Maprotiline; Methysergide; Migraine Disorders; Mutation; Pizotyline; Placebos; Propranolol; Research; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sympatholytics; Vasoconstrictor Agents	2003
Can fear extinction be enhanced? A review of pharmacological and behavioral findings. Brain research bulletin, 2014, Volume: 105 Topics: Animals; Conditioning, Classical; Extinction, Psychological; Fear; Fluoxetine; Humans; Levodopa; Neurotransmitter Agents; Propranolol; Yohimbine	2014

Trials

1 trial(s) available for fluoxetine and propranolol

Article	Year
Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2006, Volume: 8, Issue:3 Topics: Adrenergic beta-Antagonists; Adult; Attitude to Health; Double-Blind Method; Female; Fluoxetine; Humans; Male; Propranolol; Quality of Life; Recurrence; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal	2006

Article

Year

Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2006, Volume: 8, Issue:3

Topics: Adrenergic beta-Antagonists; Adult; Attitude to Health; Double-Blind Method; Female; Fluoxetine; Humans; Male; Propranolol; Quality of Life; Recurrence; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal

2006

Other Studies

70 other study(ies) available for fluoxetine and propranolol

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk). Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9 Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water	2005
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs. European journal of medicinal chemistry, 2008, Volume: 43, Issue:3 Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization	2008
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19 Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats	2007
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution	2011
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3 Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results	2011
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Glutathione; Pharmacology; Sulfur Radioisotopes	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets. Journal of medicinal chemistry, 2012, Jan-12, Volume: 55, Issue:1 Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics	2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10 Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1 Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity	2013
Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells). Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:4 Topics: Adrenergic beta-Antagonists; Amines; Ammonium Chloride; Antidepressive Agents, Tricyclic; Atorvastatin; Cell Line, Transformed; Diuretics; Hepatocytes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipramine; Lysosomes; Monensin; Nigericin; Propranolol; Pyrroles	2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1979, Volume: 11, Issue:2 Topics: 5-Hydroxytryptophan; Animals; Blood Glucose; Dose-Response Relationship, Drug; Fluoxetine; Glucagon; Insulin; Insulin Secretion; Male; Methysergide; Phentolamine; Propranolol; Propylamines; Quinolines; Quipazine; Rats	1979
Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia. The Journal of clinical psychiatry, 1991, Volume: 52, Issue:12 Topics: Adult; Akathisia, Drug-Induced; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Hospitalization; Humans; Male; Propranolol; Psychomotor Agitation; Suicide, Attempted	1991
Propanolol for fluoxetine-induced akathisia. Biological psychiatry, 1991, Sep-01, Volume: 30, Issue:5 Topics: Akathisia, Drug-Induced; Depressive Disorder; Female; Fluoxetine; Humans; Middle Aged; Neurologic Examination; Propranolol; Psychomotor Agitation	1991
Effects of endothelial cell removal on alpha-adrenoceptor-mediated responses of aortae of pregnant rats. Clinical and experimental pharmacology & physiology, 1990, Volume: 17, Issue:2 Topics: Adrenergic alpha-Agonists; Animals; Aorta; Azepines; Dose-Response Relationship, Drug; Endothelium, Vascular; Estradiol; Female; Fluoxetine; Norepinephrine; Phenylephrine; Pregnancy; Pregnancy, Animal; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Vasoconstriction	1990
Chlorpromazine, other amphiphilic cationic drugs and praziquantel: effects on carbohydrate metabolism of Schistosoma mansoni. Parasitology research, 1987, Volume: 73, Issue:3 Topics: Amitriptyline; Animals; Carbohydrate Metabolism; Chlorpromazine; Fluoxetine; Glucose; Imipramine; Lactates; Praziquantel; Propranolol; Schistosoma mansoni	1987
Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice. European journal of pharmacology, 1985, Oct-22, Volume: 116, Issue:3 Topics: Amphetamine; Animals; Cocaine; Cues; Discrimination, Psychological; Fluoxetine; Male; Mice; Mice, Inbred ICR; Motor Activity; Pimozide; Prazosin; Propranolol; Stereotyped Behavior	1985
Behavioural effects of long term inhibition of 5-hydroxytryptamine receptors using metergoline. Journal de physiologie, 1981, Volume: 77, Issue:2-3 Topics: Amitriptyline; Animals; Ergolines; Fluoxetine; Male; Metergoline; Motor Activity; Propranolol; Rats; Rats, Inbred Strains; Receptors, Serotonin	1981
Monoaminergic mechanisms and experimental cataplexy. Annals of neurology, 1981, Volume: 10, Issue:4 Topics: Animals; Antidepressive Agents, Tricyclic; Biogenic Amines; Cataplexy; Dogs; Female; Fluoxetine; Haloperidol; Humans; Male; Methylphenidate; Monoamine Oxidase Inhibitors; Physostigmine; Pimozide; Propranolol; Sleep, REM; Sodium Oxybate	1981
The effects of acute and repeated treatment with salbutamol, a beta-adrenoceptor agonist, on clonidine-induced hypoactivity in rats. Journal of neural transmission, 1982, Volume: 53, Issue:2-3 Topics: Albuterol; Animals; Clonidine; Desipramine; Drug Interactions; Exploratory Behavior; Fluoxetine; Imipramine; Male; Propranolol; Rats; Rats, Inbred Strains; Yohimbine	1982
Antidepressant and depressogenic drugs lack consistent effects on hamster circadian rhythms. Psychiatry research, 1994, Volume: 53, Issue:2 Topics: Animals; Antidepressive Agents; Arousal; Circadian Rhythm; Clonidine; Clorgyline; Cricetinae; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Male; Mesocricetus; Motor Activity; Phenelzine; Propranolol	1994
Heart block in a patient on propranolol and fluoxetine. Lancet (London, England), 1994, Feb-12, Volume: 343, Issue:8894 Topics: Fluoxetine; Heart Block; Humans; Male; Middle Aged; Propranolol	1994
Facilitatory and inhibitory effects of selective norepinephrine reuptake inhibitors on hypogastric nerve-evoked urethral contractions in the cat: a prominent role of urethral beta-adrenergic receptors. The Journal of urology, 1994, Volume: 152, Issue:2 Pt 1 Topics: Animals; Atomoxetine Hydrochloride; Cats; Dose-Response Relationship, Drug; Female; Fluoxetine; Muscle Contraction; Norepinephrine; Propranolol; Propylamines; Receptors, Adrenergic, beta; Urethra	1994
Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1993, Volume: 8, Issue:3 Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Caffeine; Designer Drugs; Dopamine Agents; Dose-Response Relationship, Drug; Fluoxetine; Indoles; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Scopolamine; Serotonin; Serotonin Receptor Agonists; Synapses	1993
Differential effects of fluoxetine on isoprenaline-stimulated water intake in ethanol-treated rats: a role for beta-adrenoceptors. European journal of pharmacology, 1993, Jun-24, Volume: 237, Issue:2-3 Topics: Analysis of Variance; Animals; Desipramine; Drinking; Drug Interactions; Ethanol; Fluoxetine; Fluvoxamine; Injections, Intraperitoneal; Isoproterenol; Male; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Zimeldine	1993
Discriminative stimulus properties of cocaine: enhancement by monoamine reuptake blockers. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 284, Issue:3 Topics: Animals; Cocaine; Desipramine; Discrimination Learning; Dopamine; Dose-Response Relationship, Drug; Fluoxetine; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Serotonin; Ventral Tegmental Area	1998
Effects of antidepressant treatment on inhibitory avoidance behavior and amygdaloid beta-adrenoceptors in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1998, Volume: 19, Issue:4 Topics: Adrenergic beta-Antagonists; Amygdala; Animals; Antidepressive Agents; Avoidance Learning; Desipramine; Fluoxetine; Injections, Intraventricular; Male; Muscarinic Antagonists; Phenelzine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Scopolamine	1998
Modulation of external pancreatic secretion by endogenous norepinephrine: study with a norepinephrine uptake blocker in the rat. Pancreas, 1999, Volume: 18, Issue:3 Topics: Acetylcholine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Deoxyglucose; Electric Stimulation; Fluoxetine; Idazoxan; Kinetics; Male; Norepinephrine; Pancreas; Prazosin; Propranolol; Rats; Rats, Wistar; Vagus Nerve; Yohimbine	1999
Protein kinase C and the sub-sensitivity and sub-reactivity of the diabetic rat prostate gland to noradrenaline. European journal of pharmacology, 2002, Jan-11, Volume: 434, Issue:3 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atropine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Fluoxetine; Immunohistochemistry; Indoles; Male; Maleimides; Methoxamine; Muscarinic Antagonists; Naphthalenes; Norepinephrine; Prazosin; Propranolol; Prostate; Protein Kinase C; Rats; Rats, Wistar	2002
Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture. Neuroscience, 2003, Volume: 118, Issue:4 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Amitriptyline; Animals; Animals, Newborn; Antidepressive Agents; Biogenic Monoamines; Blotting, Western; Carrier Proteins; Culture Techniques; DNA Primers; DNA, Complementary; Drug Interactions; Female; Fluoxetine; Gene Expression Regulation; Hippocampus; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Phenols; Piperazines; Pregnancy; Propranolol; Pyridines; Rats; Rats, Wistar; Receptors, Adrenergic; Receptors, Serotonin; Receptors, Steroid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sulfonamides	2003
Cocaine-induced modulation of long-term potentiation in the CA1 region of rat hippocampus. Neuropharmacology, 2005, Volume: 49, Issue:2 Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Benzazepines; Cocaine; Desipramine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Fluoxetine; Hippocampus; In Vitro Techniques; Lidocaine; Long-Term Potentiation; Neurotransmitter Uptake Inhibitors; Piperazines; Propranolol; Rats; Rats, Sprague-Dawley; Salicylamides; Tetrodotoxin	2005
Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats. Indian journal of experimental biology, 2005, Volume: 43, Issue:7 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antitussive Agents; Behavior, Animal; Buspirone; Central Nervous System; Dexfenfluramine; Dextromethorphan; Fluoxetine; Male; Propranolol; Rats; Rats, Wistar; Serotonin; Serotonin Receptor Agonists; Syndrome	2005
Cytochrome P450 (CYP) inhibition screening: comparison of three tests. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2006, Oct-01, Volume: 29, Issue:2 Topics: Citalopram; Cytochrome P-450 Enzyme Inhibitors; Diazepam; Enzyme Inhibitors; Fluoxetine; Humans; Oxazepam; Propranolol; Sotalol	2006
Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction. Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:8 Topics: Algorithms; Amines; Animals; Biological Transport; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Dextromethorphan; Fluoxetine; Fluvoxamine; Hepatocytes; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Imipramine; In Vitro Techniques; Kinetics; Male; Models, Biological; Propranolol; Quinine; Rats; Rats, Sprague-Dawley	2007
Noradrenergic mechanisms in cocaine-induced reinstatement of drug seeking in squirrel monkeys. The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:2 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Animals; Behavior, Addictive; Behavior, Animal; Clonidine; Cocaine; Cocaine-Related Disorders; Dopamine Uptake Inhibitors; Drug Interactions; Extinction, Psychological; Fluoxetine; Flupenthixol; Grooming; Hydrocortisone; Injections, Intravenous; Norepinephrine; Piperazines; Prazosin; Propranolol; Receptors, Adrenergic, alpha-2; Saimiri; Saliva; Self Administration; Thiophenes	2007
Comparison of sub-2-microm particle columns for fast metabolite ID. Journal of separation science, 2007, Volume: 30, Issue:8 Topics: Chromatography, Liquid; Fluoxetine; Humans; Mass Spectrometry; Microsomes, Liver; Molecular Structure; Particle Size; Pharmaceutical Preparations; Propranolol; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Verapamil	2007
Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain. European journal of pharmacology, 2010, Oct-10, Volume: 644, Issue:1-3 Topics: Animals; Brain; Fever; Fluoxetine; Glucose; Glycogenolysis; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Serotonin	2010
Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin. Physiology & behavior, 2011, Jan-10, Volume: 102, Issue:1 Topics: Adrenergic Antagonists; Animals; Antidepressive Agents; Benzazepines; Cyproheptadine; Depression; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Flavones; Fluoxetine; Hindlimb Suspension; Male; Mice; Mice, Inbred ICR; Motor Activity; Piperazines; Prazosin; Propranolol; Pyridines; Serotonin Antagonists; Sulpiride; Swimming; Yohimbine	2011
The pH-dependent toxicity of basic pharmaceuticals in the green algae Scenedesmus vacuolatus can be explained with a toxicokinetic ion-trapping model. Aquatic toxicology (Amsterdam, Netherlands), 2011, Jan-17, Volume: 101, Issue:1 Topics: Amines; Fluoxetine; Hydrogen-Ion Concentration; Kinetics; Lidocaine; Liposomes; Models, Chemical; Propranolol; Quantitative Structure-Activity Relationship; Scenedesmus; Trimipramine; Water	2011
Single-substance and mixture toxicity of five pharmaceuticals and personal care products to marine periphyton communities. Environmental toxicology and chemistry, 2011, Volume: 30, Issue:9 Topics: Animals; Aquatic Organisms; Bacteria; Clotrimazole; Drug Interactions; Fluoxetine; Microalgae; Prescription Drugs; Propranolol; Pyridines; Risk Assessment; Thiones; Triclosan; Water Microbiology	2011
Pharmacophore modeling for hERG channel facilitation. Biochemical and biophysical research communications, 2012, Feb-03, Volume: 418, Issue:1 Topics: Animals; Atenolol; Chlorpheniramine; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoxetine; Haloperidol; Humans; Hydrophobic and Hydrophilic Interactions; Imipramine; Metoprolol; Nortriptyline; Potassium Channel Blockers; Promethazine; Propranolol; Quantitative Structure-Activity Relationship; Sotalol; Terfenadine; Verapamil; Xenopus laevis	2012
The change in muscarinic receptor subtypes in different brain regions of rats treated with fluoxetine or propranolol in a model of post-traumatic stress disorder. Behavioural brain research, 2012, Jun-15, Volume: 232, Issue:1 Topics: Adrenergic beta-Antagonists; Amygdala; Animals; Anxiety; Blotting, Western; Brain Chemistry; Exploratory Behavior; Female; Fluoxetine; Hippocampus; Immunohistochemistry; Male; Odorants; Prefrontal Cortex; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Stress, Psychological	2012
Multi-residue enantiomeric analysis of pharmaceuticals and their active metabolites in the Guadalquivir River basin (South Spain) by chiral liquid chromatography coupled with tandem mass spectrometry. Analytical and bioanalytical chemistry, 2013, Volume: 405, Issue:18 Topics: Atenolol; Chromatography, Liquid; Environmental Monitoring; Fluoxetine; Metoprolol; Pharmaceutical Preparations; Propanolamines; Propranolol; Reproducibility of Results; Rivers; Sensitivity and Specificity; Spain; Stereoisomerism; Tandem Mass Spectrometry; Water Pollutants, Chemical	2013
Cyclic-AMP mediated regulation of ABCB mRNA expression in mussel haemocytes. PloS one, 2013, Volume: 8, Issue:4 Topics: 5' Untranslated Regions; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bucladesine; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Fluoxetine; Gene Expression Regulation; Hemocytes; Humans; Isoquinolines; Models, Biological; Mytilus; Norepinephrine; Promoter Regions, Genetic; Propranolol; Receptors, Serotonin, 5-HT1; RNA, Messenger; Sequence Analysis, DNA; Serotonin; Serotonin Receptor Agonists; Signal Transduction; Sulfonamides; Up-Regulation	2013
The mode of action (MOA) approach reveals interactive effects of environmental pharmaceuticals on Mytilus galloprovincialis. Aquatic toxicology (Amsterdam, Netherlands), 2013, Sep-15, Volume: 140-141 Topics: Amphibian Proteins; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Fluoxetine; Gene Expression Regulation; Mytilus; Propranolol; Water Pollutants, Chemical	2013
Response to commentary on "are some invertebrates exquisitely sensitive to the human pharmaceutical fluoxetine?". Aquatic toxicology (Amsterdam, Netherlands), 2014, Volume: 146 Topics: Animals; Fluoxetine; Gene Expression Regulation; Mytilus; Propranolol; Water Pollutants, Chemical	2014
Are some invertebrates exquisitely sensitive to the human pharmaceutical fluoxetine? Aquatic toxicology (Amsterdam, Netherlands), 2014, Volume: 146 Topics: Animals; Fluoxetine; Gene Expression Regulation; Mytilus; Propranolol; Selective Serotonin Reuptake Inhibitors; Sepia; Water Pollutants, Chemical	2014
A multibiomarker approach to explore interactive effects of propranolol and fluoxetine in marine mussels. Environmental pollution (Barking, Essex : 1987), 2015, Volume: 205 Topics: Animals; Antioxidants; Biomarkers; Environmental Monitoring; Fluoxetine; Gene Expression Regulation; Lysosomes; Mytilus; Propranolol; RNA, Messenger; Stress, Physiological; Water Pollutants, Chemical	2015
Low environmental levels of neuro-active pharmaceuticals alter phototactic behaviour and reproduction in Daphnia magna. Aquatic toxicology (Amsterdam, Netherlands), 2016, Volume: 170 Topics: Animals; Behavior, Animal; Carbamazepine; Chromatography, High Pressure Liquid; Daphnia; Fluoxetine; Light; Propranolol; Reproduction; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Toxicity Tests; Water Pollutants, Chemical	2016
Derivation of water quality guidelines for priority pharmaceuticals. Environmental toxicology and chemistry, 2016, Volume: 35, Issue:7 Topics: Animals; Aquatic Organisms; Carbamazepine; Diclofenac; Fluoxetine; Fresh Water; Guidelines as Topic; Pharmaceutical Preparations; Propranolol; Toxicity Tests, Chronic; Water Pollutants, Chemical; Water Quality	2016
Interactive effects of selected pharmaceutical mixtures on bioaccumulation and biochemical status in crucian carp (Carassius auratus). Chemosphere, 2016, Volume: 148 Topics: Animals; Cytochrome P-450 CYP1A1; Fluoxetine; Gills; Goldfish; Liver; Malondialdehyde; Muscles; Propranolol; Roxithromycin; Water Pollutants, Chemical	2016
Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect. Nature medicine, 2016, Volume: 22, Issue:10 Topics: Adrenergic beta-Antagonists; Animals; Bone and Bones; Bone Remodeling; Bone Resorption; Calcium; Fluoxetine; Gene Expression; Immunohistochemistry; In Vitro Techniques; Mice; Mice, Knockout; NFATC Transcription Factors; Optical Imaging; Osteogenesis; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sympathetic Nervous System; Tryptophan Hydroxylase; X-Ray Microtomography	2016
Assessing the environmental hazard of individual and combined pharmaceuticals: acute and chronic toxicity of fluoxetine and propranolol in the crustacean Daphnia magna. Ecotoxicology (London, England), 2017, Volume: 26, Issue:6 Topics: Adrenergic beta-Antagonists; Animals; Daphnia; Fluoxetine; Hazardous Substances; Propranolol; Selective Serotonin Reuptake Inhibitors; Toxicity Tests, Acute; Toxicity Tests, Chronic; Water Pollutants, Chemical	2017
Behavioral responses and starvation survival of Daphnia magna exposed to fluoxetine and propranolol. Chemosphere, 2018, Volume: 211 Topics: Animals; Behavior, Animal; Daphnia; Fluoxetine; Propranolol; Water Pollutants, Chemical	2018
Propranolol Reverses Impaired Fracture Healing Response Observed With Selective Serotonin Reuptake Inhibitor Treatment. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2020, Volume: 35, Issue:5 Topics: Animals; Femoral Fractures; Fluoxetine; Fracture Healing; Mice; Osteogenesis; Propranolol; Selective Serotonin Reuptake Inhibitors	2020
Depressed, hypertense and sore: Long-term effects of fluoxetine, propranolol and diclofenac exposure in a top predator fish. The Science of the total environment, 2020, Apr-10, Volume: 712 Topics: Animals; Biomarkers; Diclofenac; Fishes; Fluoxetine; Oxidative Stress; Propranolol; Water Pollutants, Chemical	2020